Akumin Inc. (TSX: AKU.U) has completed its proposed its initial public offering (IPO) by way of qualifying common shares issuable upon the exercise of previously issued or converted special warrants and broker warrants.
Akumin’s stock will commence trading at the opening of markets on December 1, 2017 under the symbol “AKU.U” on the Toronto Stock Exchange.
Riadh Zine, President and Chief Executive Officer of the Corporation, noted, “This IPO is an important milestone for Akumin and is a testament to the continued dedication and passion of our staff and the loyalty of our clientele as well as the trust placed in us by our investors.”
Toronto based Akumin is a leading provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States with a network of 71 owned and/or operated imaging centers: wholly-owned (58), partly-owned (11) or managed (2), located in Florida, Pennsylvania, Delaware, Texas, Illinois and Kansas. Aimaging procedures include MRI, CT, positron emission tomography (PET), ultrasound, diagnostic radiology (X-ray), mammography, and other interventional procedures.
photo credit: jarmoluk via pixabay